Skip to main content
. 2024 Jun 5;14(6):576. doi: 10.3390/brainsci14060576

Table 2.

Combined ROC results of the anti-mitochondrial antibodies (AMA-M2), anti-histone autoantibodies, and PLA2/COX for patient group according to control group as a reference group.

Parameters AUC Sensitivity % Specificity % p Value 95% CI
AMA-M2 with anti-histone antibodies 0.743 40.0% 100.0% 0.006 0.601–0.885
AMA-M2 with PLA2/COX 0.871 87.5% 78.6% 0.000 0.774–0.969
Anti-histone antibodies with PLA2/COX 0.909 90.0% 75.0% 0.000 0.834–0.984
AMA-M2 with anti-histone antibodies with PLA2/COX 0.941 95.0% 78.6% 0.000 0.881–1.000